Lenalidomide in relapsed and refractory multiple myeloma disease: feasibility and benefits of long-term treatment
Crossref DOI link: https://doi.org/10.1007/s00277-014-2149-2
Published Online: 2014-07-01
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zago, Manola
Oehrlein, Katharina
Rendl, Corinna
Hahn-Ast, Corinna
Kanz, Lothar
Weisel, Katja
Text and Data Mining valid from 2014-07-01